First line therapy in stage IV BRAF mutated colorectal cancer
Introduction: The molecular profile of colorectal cancer (CRC) plays a crucial role in understanding patient prognosis and treatment response. Within CRC, a distinct subgroup can be identified by the presence of the BRAF V600E mutation. This specific mutation, classified as Class I of BRAF mutations...
Na minha lista:
| Principais autores: | , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Elsevier
2024-09-01
|
| Serier: | Heliyon |
| Fag: | |
| Online adgang: | http://www.sciencedirect.com/science/article/pii/S2405844024125285 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
